CompletedNCT02712996
Official study titleTreatment Outcomes With Lisdexamfetamine Dimesylate (Vyvanse) in Children With Traumatic Brain Injury-Related Attention Deficits
This study has finished and is no longer accepting participants.
In NashvilleADHDMedication studyAges 6–16
- Countries
- United States
- Sponsor
- Vanderbilt University
CompletedACTRN12616001111460
Official study titleImproving attention and learning capacity in early childhood via a computerised cognitive training program: a randomised controlled trial
This study has finished and is no longer accepting participants.
In AustraliaADHDInterventional studyAges 4–8
- Countries
- Australia
- Sponsor
- Monash University
CompletedACTRN12623000511639
Official study titleA randomised controlled trial investigating the use of remote microphone technology to manage listening difficulties in children with attention deficits
This study has finished and is no longer accepting participants.
In ParkvilleADHDInterventional studyAges 6–12
- Countries
- Australia
- Sponsor
- University of Melbourne
CompletedACTRN12623000512628
Official study titleAn extension trial to determine the effect of remote microphone technology to manage listening difficulties in children with attention deficits
This study has finished and is no longer accepting participants.
In ParkvilleADHDInterventional studyAges 6–12
- Countries
- Australia
- Sponsor
- University of Melbourne
TerminatedEUCTR 2018-001166-42
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In ItalyADHDHistorical research record
- Countries
- Italy, Spain
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco ACRAF S.p.A (Angelini S.p.A.)
CompletedEUCTR 2009-018161-12
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumADHDHistorical research record
- Countries
- United Kingdom, Belgium, Germany, + 4 others
- Sponsor
- Shire Development Inc
CompletedEUCTR 2010-020014-28
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In NetherlandsADHDHistorical research record
- Countries
- Netherlands
- Sponsor
- Centre for Human Drug Research
CompletedNCT00421603
Official study titleA Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) and Topiramate for the Treatment of Cocaine Dependence
This study has finished and is no longer accepting participants.
In New YorkADHDMedication studyAges 18–60
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
CompletedNCT02250339
Official study titlePhase 2: A Prospective Observational Study of Feasibility and Tentative Effectiveness of Multi-Systemic and Multicomponent Family-Based Intervention for Families of Children With Neuropsychiatric and/or Psychiatric Disorder(s).
This study has finished and is no longer accepting participants.
In HelsinkiADHDObservational studyAges 5–12
- Countries
- Finland
- Sponsor
- Social Insurance Institution, Finland
UnknownNCT06479850
Current recruitment status is unconfirmed.
Location not clearly listedADHDBehavioural studyAges 14–26
- Countries
- Sponsor
- Kessler Foundation
CompletedNCT00236444
Official study titleRisperidone in the Prevention of Relapse: a Randomized, Double-blind, Placebo-controlled Trial in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders.
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 5–17
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT00250354
Official study titleThe Safety And Efficacy Of Risperidone Versus Placebo In Conduct Disorder In Mild, Moderate And Borderline Mentally Retarded Children Aged 5 To 12 Years
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 5–12
- Countries
- Sponsor
- Janssen Pharmaceutica N.V., Belgium